Esperion Therapeutics, Inc. (ESPR) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 13, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 13, 2026 | Hoffman Robert E. Director | $0 | 132,193 | −100% | No | |
|
|
||||||
| July 13, 2026 | CARROLL J MARTIN Director | $0 | 275,023 | −100% | No | |
|
|
||||||
| July 13, 2026 | Shepard Jay Director | $0 | 261,972 | −100% | No | |
|
|
||||||
| July 13, 2026 | Fischer Seth H. Z. Director | $0 | 238,523 | −100% | No | |
|
|
||||||
| July 13, 2026 | Halladay Benjamin Chief Financial Officer | $0 | 1,339,680 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free